{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:08:06Z","timestamp":1784696886735,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.vaccine.2020.10.050","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T20:02:17Z","timestamp":1603396937000},"page":"7741-7746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Lessons learned in the implementation of supplementary immunization activity (SIA) field guidelines for injectable vaccines \u2013 Experiences from Tanzania"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5813-4579","authenticated-orcid":false,"given":"Nassor","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daudi","family":"Simba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Mphuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafrossa","family":"Lyimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furaha","family":"Kyesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.10.050_b0005","unstructured":"World Health Organization. Measles elimination by 2020: a strategy for the African Region. Resolution AFR\/RC61\/R1oftheSixty-first session of the WHO Regional Committee for Africa, Yamoussoukro, C\u00f4te d\u2019Ivoire, 29August\u20132 September2011, Final Report, Brazzaville, Congo, World Health Organization, Regional Office for Africa, 2011(AFR\/RC61\/14) pp.7-8.https:\/\/www.afro.who.int\/sites\/default\/files\/sessions\/resolutions\/AFR-RC61-R1-Measles-elimination-by-2020---A-strategy-for-the-African-Region.pdf."},{"key":"10.1016\/j.vaccine.2020.10.050_b0010","unstructured":"Regional Committee for Africa, 67. (2017). Progress towards measles elimination in the African Region by 2020. World Health Organization. Regional Office for Africa.https:\/\/apps.who.int\/iris\/handle\/10665\/260250."},{"key":"10.1016\/j.vaccine.2020.10.050_b0015","unstructured":"African regional guidelines for measles and rubella surveillance-draft version April 2015.https:\/\/www.afro.who.int\/sites\/default\/files\/2017-06\/who-african-regional-measles-and-rubella-surveillance-guidelines_updated-draft-version-april-2015_1.pdf."},{"key":"10.1016\/j.vaccine.2020.10.050_b0020","unstructured":"WHO (2010). Global Vaccine Action Plan (GVAP) 2011-2020. Geneva: World Health Organization.https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/78141\/9789241504980_eng.pdf;jsessionid=B9115FE5737080617824C8436938D791?sequence=1."},{"key":"10.1016\/j.vaccine.2020.10.050_b0025","unstructured":"World Health Organization. Planning and implementing high quality supplementary immunization activities for injectable vaccines using an example of measles and rubella vaccine: field guide. Geneva, Switzerland: World Health Organization; 2016.https:\/\/www.who.int\/immunization\/diseases\/measles\/SIA-Field-Guide.pdf?ua=1."},{"key":"10.1016\/j.vaccine.2020.10.050_b0030","unstructured":"Muhimbili University of Health And Allied Sciences (MUHAS). Post integrated measles rubella SIAsevaluation and routine immunization coverage survey 2014: MUHAS; May, 2015"},{"key":"10.1016\/j.vaccine.2020.10.050_b0035","unstructured":"United Republic of Tanzania: WHO and UNICEF estimates of immunization coverage: 2019 revision. https:\/\/www.who.int\/immunization\/monitoring_surveillance\/data\/tza.pdf."},{"key":"10.1016\/j.vaccine.2020.10.050_b0040","unstructured":"United Republich of Tanzania, Ministry of Health Community Development Gender Elderly and Children. Integrated measles rubella follow-up campaign field guideline, 2019."},{"key":"10.1016\/j.vaccine.2020.10.050_b0045","unstructured":"Ifakara health institute (IHI). Post measles-rubella SIAsevaluation in Tanzania 2019: IHI; January, 2020"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.050_b0050","doi-asserted-by":"crossref","DOI":"10.1186\/s12961-018-0400-3","article-title":"Understanding the implementation of Direct Health Facility Financing and its effect on health system performance in Tanzania: a non-controlled before and after mixed method study protocol","volume":"17","author":"Kapologwe","year":"2019","journal-title":"Health Res Policy Sys"},{"key":"10.1016\/j.vaccine.2020.10.050_b0055","doi-asserted-by":"crossref","unstructured":"Stashko LA, Gacic-Dobo M, Dumolard LB, Danovaro-Holliday MC. Assessing the quality and accuracy of the national immunization program reported target population estimates from 2000 to 2016. PLoS One. 2019;14(7):e0216933. Published 2019 Jul 9. doi:10.1371\/journal.pone.0216933","DOI":"10.1371\/journal.pone.0216933"},{"key":"10.1016\/j.vaccine.2020.10.050_b0060","unstructured":"Ministry of Health, Community Development, Gender, Elderly and Children, United Republic of Tanzania. Plan of action for measles rubella follow up SIAs, 2019.Submitted to Gavi as part of application for measles rubella SIAs grant application, May, 2018"},{"key":"10.1016\/j.vaccine.2020.10.050_b0065","unstructured":"Population Reference Bureau. (2001) Understanding and using population projections. Washington, DC. http:\/\/www.prb.org\/pdf\/UnderStndPopProj_Eng.pdf on 10 June 2020"},{"issue":"03","key":"10.1016\/j.vaccine.2020.10.050_b0070","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4236\/wjv.2014.43012","article-title":"Avoiding the Will O\u2019 the Wisp: Challenges in Measuring High Levels of Immunization Coverage with Precision","volume":"04","author":"Brown","year":"2014","journal-title":"WJV"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.050_b0075","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.vaccine.2005.08.077","article-title":"Vaccination coverage survey versus administrative data in the assessment of mass yellow fever immunization in internally displaced persons\u2014Liberia, 2004","volume":"24","author":"Huhn","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.10.050_b0080","first-page":"501","article-title":"Using lot quality assurance sampling to improve immunization coverage in Bangladesh","volume":"79","author":"Tawfik","year":"2001","journal-title":"Bull World Health Organization"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.050_b0085","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/ije\/23.3.624","article-title":"Measles Control in Kinshasa, Zaire Improved with High Coverage and Use of Medium Titre Edmonston Zagreb Vaccine at Age 6 Months","volume":"23","author":"Cutts","year":"1994","journal-title":"Int J Epidemiol"},{"issue":"5","key":"10.1016\/j.vaccine.2020.10.050_b0090","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2471\/BLT.14.146050","article-title":"Surveys of measles vaccination coverage in eastern and southern Africa: a review of quality and methods used","volume":"93","author":"Kaiser","year":"2015","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.vaccine.2020.10.050_b0095","doi-asserted-by":"crossref","unstructured":"Hersh BS, Carr RM, Fitzner J, Goodman TS, Mayers GF, Everts H, Laurent E, Larsen GA, Bilous JB. Ensuring injection safety during measles immunization SIAss: more than auto-disable syringes and safety boxes. J Infect Dis. 2003;187:S299\u2013306.https:\/\/doi.org\/10.1086\/368227","DOI":"10.1086\/368227"},{"issue":"7","key":"10.1016\/j.vaccine.2020.10.050_b0100","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.socscimed.2006.04.025","article-title":"Perspectives on polio and immunization in Northern Nigeria","volume":"63","author":"Renne","year":"2006","journal-title":"Soc Sci Med"},{"issue":"11","key":"10.1016\/j.vaccine.2020.10.050_b0105","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1473-3099(09)70268-3","article-title":"Has routine immunisation in Africa become endangered?","volume":"9","author":"Berhane","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.10.050_b0110","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4236\/wjv.2012.21006","article-title":"Achieving polio eradication: A need for innovative strategies","volume":"2","author":"Keugoung","year":"2012","journal-title":"World J Vaccine"},{"key":"10.1016\/j.vaccine.2020.10.050_b0115","series-title":"Social Determinants Approaches to Public Health: From Concept to Practice","first-page":"105","article-title":"Immunization programme in Anambra state, Nigeria: An analysis of policy development and implementation of the reaching every ward strategy","author":"Uzochukwu","year":"2011"},{"key":"10.1016\/j.vaccine.2020.10.050_b0120","first-page":"194","article-title":"Reasons for incomplete vaccination and factors for missed opportunities among rural Nigerian children","volume":"3","author":"Abdulraheem","year":"2011","journal-title":"J Public Health Epidemiol"},{"key":"10.1016\/j.vaccine.2020.10.050_b0125","unstructured":"Romania: Measles\/Rubella Vaccination Social Mobilization SIAs. IFRC. In: IFRC final report; 1999. Available at: https:\/\/www.alnap.org\/system\/files\/content\/resource\/files\/main\/romania.pdf."},{"key":"10.1016\/j.vaccine.2020.10.050_b0130","unstructured":"Gavi. Gavi Full Country Evaluation 2013: Process evaluation of pneumococcal vaccine introduction in Mozambique, Uganda, and Zambia. GAVI; 2014. Available at: http:\/\/www.healthdata.org\/sites\/default\/files\/files\/Projects\/GAVI\/GAVI_Full_Country_Evaluation_PCV_Findings_2014.pdf"},{"key":"10.1016\/j.vaccine.2020.10.050_b0135","doi-asserted-by":"crossref","unstructured":"BalchaMasresha et al. The use of WhatsApp group messaging in the coordination of measles supplemental immunization activity in Cross Rivers State, Nigeria, 2018 . The Pan African Medical Journal. 2020;35 (Supp 1):6.","DOI":"10.11604\/pamj.supp.2020.35.1.19216"},{"key":"10.1016\/j.vaccine.2020.10.050_b0140","unstructured":"Implementing Best Practice Measles SIAs, the Ethiopia Experience, May 2011 https:\/\/www.unicef.org\/evaldatabase\/files\/2011_Esaro_Regional_SIA_evaluation_report.pdf"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.050_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.1681-4835.2006.tb00171.x","article-title":"Strategies for Developing Human Resource Capacity to Support Sustainability of ICT Based Health Information Systems: A Case Study from Tanzania","volume":"26","author":"Kimaro","year":"2006","journal-title":"Electronic J Info Syst Developing Countries"},{"key":"10.1016\/j.vaccine.2020.10.050_b0150","first-page":"150","article-title":"Low-cost on-the-job peer training of nurses improved immunization coverage in Indonesia","volume":"79","author":"Robinson","year":"2001","journal-title":"Bull World Health Organ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20313566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20313566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:47:47Z","timestamp":1759402067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20313566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":30,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0264410X20313566"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.10.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lessons learned in the implementation of supplementary immunization activity (SIA) field guidelines for injectable vaccines \u2013 Experiences from Tanzania","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.10.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}